Dergiler / Southern Clinics of Istanbul Eurasia / 2022 / Cilt: 33 - Sayı: 2

Long-Term Results of Fine Needle Diathermy Occlusion of Corneal Vessels in the Treatment of Herpetic Corneal Neovascularization

Sayfa
180–184
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our results indicated that FND treatment in CoNV due to herpetic keratitis was effective in preventing CoNV recurrence, and the visual acuity gained after FND treat- ment was preserved in the long-term follow-up.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aimed to evaluate the long-term results of fine needle diathermy (FND) in the treatment of corneal neovascularization (CoNV) due to herpetic keratitis.
📊
Temel Bulgular & Veri:Results: Twelve eyes of 12 patients with herpetic keratitis CoNV were included in the study.
💡
Sonuç & Katkı:Conclusion: Our results indicated that FND treatment in CoNV due to herpetic keratitis was effective in preventing CoNV recurrence, and the visual acuity gained after FND treat- ment was preserved in the long-term follow-up.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: This study aimed to evaluate the long-term results of fine needle diathermy (FND) in the treatment of corneal neovascularization (CoNV) due to herpetic keratitis. Methods: We retrospectively reviewed the data of patients with herpetic keratitis CoNV who underwent FND. The demographic data, intraoperative and postoperative complica- tions, preoperative and postoperative best corrected visual acuity (BCVA), and the number of FND procedure were recorded. Results: Twelve eyes of 12 patients with herpetic keratitis CoNV were included in the study. Two patients (16.7%) were females and 10 were males (83.3%). The mean age was 56.75±13.24 (39–88) years. The mean follow-up period was 20.58±9.79 (12–42) months. The mean number of FND was 1.33±0.65. The mean preoperative BCVA was 1.40±0.44 log MAR, and the mean postoperative BCVA was 1.11±0.52 log MAR (p=0.018). All eyes with herpetic CoNV were categorized based on the resolution of corneal vascularization and visual acuity improvement into complete regression (n=6, 50%), partial regression (n=4, 33.3%), and no regression (n=2, 16.7%). Subconjunctival hemorrhage developed in 2 patients (16.7%). Corneal perforation developed in 1 patient (8.3%) and was treated conservatively. During the follow-up period, no patient had CoNV activation after FND. Conclusion: Our results indicated that FND treatment in CoNV due to herpetic keratitis was effective in preventing CoNV recurrence, and the visual acuity gained after FND treat- ment was preserved in the long-term follow-up.

🔖

Bu Makaleye Atıf Yap

Göktaş, E., Kandemir, B., Tanyıldız, B., Kaya, B., Kanar, H. S., Günaydın, N. T. (2022). Long-Term Results of Fine Needle Diathermy Occlusion of Corneal Vessels in the Treatment of Herpetic Corneal Neovascularization. Southern Clinics of Istanbul Eurasia, Cilt: 33 - Sayı: 2, 180–184. https://ajindex.com/articles/592718

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (20)

  1. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol 1990;48:191–226
  2. Conn H, Berman M, Kenyon K, Langer R, Gage J. Stromal vascu- larization prevents corneal ulceration. Invest Ophthalmol Vis Sci 1980;19:362–70
  3. Küçükibak Yıldırım N. Kornea neovaskülarizasyonu ve tedavisi. Tür- kiye Klinikleri Oftalmoloji Dergisi 2017;26:37–48
  4. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996;37:2485–94
  5. Alldredge OC, Krachmer JH. Clinical types of corneal transplant re- jection: their manifestations, frequency, preoperative correlates, and treatment. Arch of Ophthalmol 1981;99:599–604
  6. Ainslie D, Snelling MD, Ellis R. Treatment of corneal vascularization by strontium 90 beta plaque. Clin Symp 1962;13:29
  7. Lavergne G, Colmant I. Comparative study of the action of thiotepa and triamcinolone on corneal vascularization in rabbits. Br J Oph- thalmol 1964;48:416
  8. Mayer W. Cryotherapy in corneal vascularization. Arch of Ophthal- mol 1967;77:637–41
  9. Lueder GT, Culican S. Yellow dye laser treatment of vascularized corneal stromal scars in pediatric patients. Arch of Ophthalmol 2008;126:564–66
  10. Çelik T, Köşker M. Korneal neovaskülarizasyon tedavisinde bevasi- zumab kullanımı. Turk J of Ophthalmol 2015;45:31–6
  11. Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 2000;41:2148–53
  12. Trikha S, Parikh S, Osmond C, Anderson DF, Hossain PN. Long- term outcomes of Fine Needle Diathermy for established corneal neovascularisation. Br J Ophthalmol 2014;98:454–8
  13. Liesegang TJ. Herpes simplex virus epidemiology and ocular impor- tance. Cornea 2001;20:1–13
  14. Valerio GS, Lin CC. Ocular manifestations of herpes simplex virus. Curr Opin Ophthalmol 2019;30:525–31
  15. Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res 2006;25:355–80
  16. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization pro- cess during the pathogenesis of herpetic stromal keratitis. J Virol 2001;75:9828–35
  17. Doggart JH. Vascularization of the crnea. Br J Ophthalmol 1951;35:160
  18. Klintworth GK. Corneal angiogenesis: A comprehensive critical re- view. New York: Springer-Verlag; 1991. p. 11–2
  19. Ey RC, Hughes WF, Bloome MA, Tallman CB. Prevention of corneal vascularization. Am J Ophthalmol 1968;66:1118–31
  20. Guidera AC, Luchs